SIMILAR PATTERNS OF AMINO ACIDS FOR 2OTH_A_NIMA300

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a6c TOBACCO RINGSPOT
VIRUS CAPSID PROTEIN

(Tobacco
ringspot virus) 		PF03391
(Nepo_coat)
PF03688
(Nepo_coat_C)
PF03689
(Nepo_coat_N) 		4 LEU A 185
ALA A 190
ILE A 191
SER A 230
 None
 1.09A 2othA-1a6cA:
0.0		 2othA-1a6cA:
12.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g0v PROTEASE A INHIBITOR
3
PROTEINASE A

(Saccharomyces
cerevisiae) 		PF00026
(Asp)
PF10466
(Inhibitor_I34) 		4 LEU A 220
ILE A 286
SER A 284
LYS B  16
 None
 1.16A 2othA-1g0vA:
0.0		 2othA-1g0vA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i74 PROBABLE
MANGANESE-DEPENDENT
INORGANIC
PYROPHOSPHATASE

(Streptococcus
mutans) 		PF01368
(DHH)
PF02833
(DHHA2) 		4 LEU A  38
ALA A  15
ILE A  16
SER A  19
 None
MN  A 401 ( 4.1A)
None
None
 0.86A 2othA-1i74A:
undetectable		 2othA-1i74A:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iyx ENOLASE

(Enterococcus
hirae) 		PF00113
(Enolase_C)
PF03952
(Enolase_N) 		4 LEU A 141
ALA A 381
ILE A 389
SER A 378
 None
 1.13A 2othA-1iyxA:
undetectable		 2othA-1iyxA:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j5t INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE

(Thermotoga
maritima) 		PF00218
(IGPS) 		4 LEU A  59
ALA A  29
ILE A  36
LYS A  86
 None
 0.96A 2othA-1j5tA:
undetectable		 2othA-1j5tA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jcm INDOLE-3-GLYCEROL-PH
OSPHATE SYNTHASE

(Escherichia
coli) 		PF00218
(IGPS) 		4 LEU P  87
ALA P  57
ILE P  64
LYS P 114
 None
None
None
137  P 400 (-2.4A)
 1.00A 2othA-1jcmP:
undetectable		 2othA-1jcmP:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jjo NEUROSERPIN

(Mus musculus) 		PF00079
(Serpin) 		4 LEU E 383
ALA C 347
ILE C 338
SER C 345
 None
 1.17A 2othA-1jjoE:
undetectable		 2othA-1jjoE:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k20 MANGANESE-DEPENDENT
INORGANIC
PYROPHOSPHATASE

(Streptococcus
gordonii) 		PF01368
(DHH)
PF02833
(DHHA2) 		4 LEU A  40
ALA A  16
ILE A  17
SER A  20
 None
MN  A 701 ( 4.0A)
None
None
 0.98A 2othA-1k20A:
undetectable		 2othA-1k20A:
17.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q6v PHOSPHOLIPASE A2
VRV-PL-VIIIA

(Daboia russelii) 		PF00068
(Phospholip_A2_1) 		4 LEU A   2
ALA A  18
ILE A  19
SER A  23
 None
 0.80A 2othA-1q6vA:
24.9		 2othA-1q6vA:
95.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qdb CYTOCHROME C NITRITE
REDUCTASE

(Sulfurospirillum
deleyianum) 		PF02335
(Cytochrom_C552) 		4 LEU A  76
ALA A  85
ILE A  84
SER A  87
 None
 1.12A 2othA-1qdbA:
undetectable		 2othA-1qdbA:
12.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1s8h PHOSPHOLIPASE A2
HOMOLOG

(Agkistrodon
contortrix) 		PF00068
(Phospholip_A2_1) 		4 LEU A   2
ALA A  18
ILE A  19
LYS A  69
 None
 0.30A 2othA-1s8hA:
21.0		 2othA-1s8hA:
64.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1spx SHORT-CHAIN
REDUCTASE FAMILY
MEMBER (5L265)

(Caenorhabditis
elegans) 		PF13561
(adh_short_C2) 		4 ALA A 165
ILE A 164
SER A 163
LYS A 109
 None
 1.10A 2othA-1spxA:
undetectable		 2othA-1spxA:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sxj ACTIVATOR 1 40 KDA
SUBUNIT

(Saccharomyces
cerevisiae) 		PF13177
(DNA_pol3_delta2) 		4 LEU E 219
ALA E 223
ILE E 198
SER E 233
 None
 1.11A 2othA-1sxjE:
undetectable		 2othA-1sxjE:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w5f CELL DIVISION
PROTEIN FTSZ

(Thermotoga
maritima) 		PF00091
(Tubulin)
PF12327
(FtsZ_C) 		4 LEU A 171
ALA A 128
ILE A 111
SER A 124
 None
 1.10A 2othA-1w5fA:
undetectable		 2othA-1w5fA:
15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1whv POLY(A)-SPECIFIC
RIBONUCLEASE

(Mus musculus) 		PF08675
(RNA_bind) 		4 LEU A 457
ALA A 487
ILE A 499
SER A 491
 None
 1.01A 2othA-1whvA:
undetectable		 2othA-1whvA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xer FERREDOXIN

(Sulfurisphaera
tokodaii) 		PF13187
(Fer4_9) 		4 LEU A  44
ALA A  70
ILE A  46
LYS A   1
 None
None
F3S  A 104 (-4.6A)
None
 1.14A 2othA-1xerA:
undetectable		 2othA-1xerA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ykg SULFITE REDUCTASE
[NADPH] FLAVOPROTEIN
ALPHA-COMPONENT

(Escherichia
coli) 		PF00258
(Flavodoxin_1) 		4 LEU A 110
ALA A 203
SER A 206
LYS A 109
 None
 1.15A 2othA-1ykgA:
1.9		 2othA-1ykgA:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yvp 60-KDA SS-A/RO
RIBONUCLEOPROTEIN

(Xenopus laevis) 		PF05731
(TROVE) 		4 LEU A 278
ALA A 356
ILE A 324
SER A 360
 A  G  10 ( 4.3A)
None
None
None
 1.16A 2othA-1yvpA:
undetectable		 2othA-1yvpA:
13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zq7 HYPOTHETICAL PROTEIN
MM0484

(Methanosarcina
mazei) 		PF01871
(AMMECR1) 		4 LEU A  22
ALA A  78
ILE A  79
SER A  80
 None
 1.13A 2othA-1zq7A:
undetectable		 2othA-1zq7A:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a1x PHYTANOYL-COA
DIOXYGENASE

(Homo sapiens) 		PF05721
(PhyH) 		4 LEU A 206
ALA A 277
ILE A 159
SER A 279
 None
AKG  A 451 ( 4.5A)
AKG  A 451 (-3.5A)
None
 1.13A 2othA-2a1xA:
undetectable		 2othA-2a1xA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c0g WINDBEUTEL PROTEIN

(Drosophila
melanogaster) 		PF07749
(ERp29)
PF07912
(ERp29_N) 		4 LEU A1076
ALA A1072
ILE A1144
SER A1068
 None
 1.10A 2othA-2c0gA:
undetectable		 2othA-2c0gA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ch6 N-ACETYL-D-GLUCOSAMI
NE KINASE

(Homo sapiens) 		PF01869
(BcrAD_BadFG) 		4 LEU A  19
ALA A 316
SER A  70
LYS A  57
 None
 0.74A 2othA-2ch6A:
undetectable		 2othA-2ch6A:
15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dkd PHOSPHOACETYLGLUCOSA
MINE MUTASE

(Candida
albicans) 		PF00408
(PGM_PMM_IV)
PF02878
(PGM_PMM_I) 		4 LEU A 315
ALA A 441
ILE A 428
SER A 437
 None
 0.97A 2othA-2dkdA:
undetectable		 2othA-2dkdA:
14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2enx MANGANESE-DEPENDENT
INORGANIC
PYROPHOSPHATASE

(Streptococcus
agalactiae) 		PF01368
(DHH)
PF02833
(DHHA2) 		4 LEU A  40
ALA A  16
ILE A  17
SER A  20
 None
MN  A 401 ( 3.9A)
None
None
 0.93A 2othA-2enxA:
undetectable		 2othA-2enxA:
17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f2a ASPARTYL/GLUTAMYL-TR
NA(ASN/GLN)
AMIDOTRANSFERASE
SUBUNIT B

(Staphylococcus
aureus) 		PF02637
(GatB_Yqey)
PF02934
(GatB_N) 		4 LEU B 375
ALA B 386
ILE B 385
SER B 382
 None
 1.16A 2othA-2f2aB:
undetectable		 2othA-2f2aB:
11.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gnx HYPOTHETICAL PROTEIN

(Mus musculus) 		PF09404
(DUF2003) 		4 LEU A 266
ALA A 200
ILE A 204
SER A 212
 None
 0.92A 2othA-2gnxA:
undetectable		 2othA-2gnxA:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hg4 6-DEOXYERYTHRONOLIDE
B SYNTHASE

(Saccharopolyspora
erythraea) 		PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF08990
(Docking)
PF16197
(KAsynt_C_assoc) 		4 LEU A 571
ALA A 579
ILE A 582
SER A 623
 None
 1.10A 2othA-2hg4A:
2.4		 2othA-2hg4A:
7.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jg7 ANTIQUITIN

(Acanthopagrus
schlegelii) 		PF00171
(Aldedh) 		4 LEU A  18
ALA A  49
ILE A  48
SER A  39
 None
 1.08A 2othA-2jg7A:
undetectable		 2othA-2jg7A:
12.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2k7h STRESS-INDUCED
PROTEIN SAM22

(Glycine max) 		PF00407
(Bet_v_1) 		4 LEU A 142
ALA A  33
ILE A  30
LYS A 138
 None
 1.07A 2othA-2k7hA:
undetectable		 2othA-2k7hA:
23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kij COPPER-TRANSPORTING
ATPASE 1

(Homo sapiens) 		PF00122
(E1-E2_ATPase) 		4 LEU A   7
ALA A  86
ILE A  85
SER A  88
 None
 0.98A 2othA-2kijA:
undetectable		 2othA-2kijA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kqk NIFU-LIKE PROTEIN

(Escherichia
coli) 		PF01592
(NifU_N) 		4 LEU A  99
ALA A  68
ILE A  67
SER A  70
 None
 0.95A 2othA-2kqkA:
undetectable		 2othA-2kqkA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p0w HISTONE
ACETYLTRANSFERASE
TYPE B CATALYTIC
SUBUNIT

(Homo sapiens) 		PF10394
(Hat1_N) 		4 LEU A 215
ALA A  80
ILE A  79
SER A  82
 None
 1.08A 2othA-2p0wA:
undetectable		 2othA-2p0wA:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q14 PHOSPHOHYDROLASE

(Bacteroides
thetaiotaomicron) 		PF01966
(HD) 		4 LEU A 151
ALA A  69
ILE A  70
LYS A 148
 None
 1.16A 2othA-2q14A:
undetectable		 2othA-2q14A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qk2 LP04448P

(Drosophila
melanogaster) 		PF12348
(CLASP_N) 		4 LEU A 347
ALA A 387
ILE A 388
SER A 391
 None
 1.01A 2othA-2qk2A:
undetectable		 2othA-2qk2A:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qo3 ERYAII ERYTHROMYCIN
POLYKETIDE SYNTHASE
MODULES 3 AND 4

(Saccharopolyspora
erythraea) 		PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc) 		4 LEU A 577
ALA A 585
ILE A 588
SER A 632
 None
 1.06A 2othA-2qo3A:
1.5		 2othA-2qo3A:
7.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2taa TAKA-AMYLASE A

(Aspergillus
oryzae) 		PF00128
(Alpha-amylase)
PF09260
(DUF1966) 		4 LEU A 462
ALA A 394
ILE A 407
SER A 409
 None
 1.14A 2othA-2taaA:
undetectable		 2othA-2taaA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v95 CORTICOSTEROID-BINDI
NG GLOBULIN

(Rattus
norvegicus) 		PF00079
(Serpin) 		4 LEU A 320
ALA A 318
ILE A 171
SER A  39
 None
 0.88A 2othA-2v95A:
undetectable		 2othA-2v95A:
14.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xua 3-OXOADIPATE
ENOL-LACTONASE

(Paraburkholderia
xenovorans) 		PF12146
(Hydrolase_4) 		4 LEU A 228
ALA A 220
ILE A 129
SER A 100
 None
 1.08A 2othA-2xuaA:
undetectable		 2othA-2xuaA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yhg CELLULOSE-BINDING
PROTEIN

(Saccharophagus
degradans) 		PF07632
(DUF1593) 		4 LEU A 912
ALA A 895
ILE A 887
SER A 890
 None
 1.11A 2othA-2yhgA:
undetectable		 2othA-2yhgA:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ys1 DYNAMIN-2

(Homo sapiens) 		PF00169
(PH) 		4 LEU A  38
ALA A 111
ILE A   9
SER A 107
 None
 1.10A 2othA-2ys1A:
undetectable		 2othA-2ys1A:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zyv TYROSINE-ESTER
SULFOTRANSFERASE

(Mus musculus) 		PF00685
(Sulfotransfer_1) 		4 LEU X  12
ALA X  25
ILE X  24
SER X  23
 None
 1.15A 2othA-2zyvX:
undetectable		 2othA-2zyvX:
15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3af5 PUTATIVE
UNCHARACTERIZED
PROTEIN PH1404

(Pyrococcus
horikoshii) 		PF07521
(RMMBL)
PF10996
(Beta-Casp)
PF16661
(Lactamase_B_6)
PF17214
(KH_7) 		4 ALA A 465
ILE A 468
SER A 150
LYS A 293
 None
 1.13A 2othA-3af5A:
undetectable		 2othA-3af5A:
12.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c17 L-ASPARAGINASE
PRECURSOR

(Escherichia
coli) 		PF01112
(Asparaginase_2) 		4 LEU A 185
ALA A 226
SER A 224
LYS A   3
 None
 1.12A 2othA-3c17A:
undetectable		 2othA-3c17A:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d45 POLY(A)-SPECIFIC
RIBONUCLEASE PARN

(Mus musculus) 		PF01424
(R3H)
PF04857
(CAF1)
PF08675
(RNA_bind) 		4 LEU A 457
ALA A 487
ILE A 499
SER A 491
 None
 0.89A 2othA-3d45A:
undetectable		 2othA-3d45A:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fid PUTATIVE OUTER
MEMBRANE PROTEIN
(LPXR)

(Salmonella
enterica) 		PF09982
(DUF2219) 		4 LEU A 239
ALA A  78
ILE A 137
SER A  80
 None
 1.13A 2othA-3fidA:
undetectable		 2othA-3fidA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h1t TYPE I SITE-SPECIFIC
RESTRICTION-MODIFICA
TION SYSTEM, R
(RESTRICTION)
SUBUNIT

(Vibrio
vulnificus) 		PF00271
(Helicase_C)
PF04851
(ResIII)
PF13588
(HSDR_N_2) 		4 ALA A 280
ILE A 281
SER A 284
LYS A 322
 None
 1.06A 2othA-3h1tA:
undetectable		 2othA-3h1tA:
11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ha4 MIX1

(Leishmania
major) 		no annotation 4 LEU A 143
ALA A 173
ILE A 170
SER A 171
 None
 1.16A 2othA-3ha4A:
undetectable		 2othA-3ha4A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3im9 MALONYL COA-ACYL
CARRIER PROTEIN
TRANSACYLASE

(Staphylococcus
aureus) 		PF00698
(Acyl_transf_1) 		4 LEU A  22
ALA A  75
ILE A  32
SER A  71
 None
 1.16A 2othA-3im9A:
undetectable		 2othA-3im9A:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3krm INSULIN-LIKE GROWTH
FACTOR 2
MRNA-BINDING PROTEIN
1

(Homo sapiens) 		PF00013
(KH_1) 		4 LEU A 513
ALA A 519
ILE A 539
SER A 546
 None
 1.15A 2othA-3krmA:
undetectable		 2othA-3krmA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lma STAGE V SPORULATION
PROTEIN AD (SPOVAD)

(Bacillus
licheniformis) 		PF07451
(SpoVAD) 		4 LEU A  81
ALA A 118
ILE A 117
SER A 121
 None
 1.10A 2othA-3lmaA:
undetectable		 2othA-3lmaA:
15.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n4p TERMINASE SUBUNIT
UL89 PROTEIN

(Human
betaherpesvirus
5) 		PF02499
(DNA_pack_C) 		4 LEU A 548
ALA A 507
ILE A 508
SER A 504
 None
 1.15A 2othA-3n4pA:
undetectable		 2othA-3n4pA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oc8 TOXIN COREGULATED
PILUS BIOSYNTHESIS
PROTEIN F

(Vibrio cholerae) 		PF06340
(TcpF) 		4 LEU A 201
ALA A 209
ILE A 208
SER A 272
 None
None
None
GOL  A 502 ( 4.5A)
 1.16A 2othA-3oc8A:
undetectable		 2othA-3oc8A:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3om9 LACTATE
DEHYDROGENASE

(Toxoplasma
gondii) 		PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C) 		4 LEU A  51
ALA A  24
ILE A  26
LYS A  62
 None
 1.13A 2othA-3om9A:
undetectable		 2othA-3om9A:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3on6 UNCHARACTERIZED
PROTEIN

(Bacteroides
ovatus) 		PF06824
(Glyco_hydro_125) 		4 LEU A 257
ALA A 281
ILE A 179
SER A 277
 None
 0.99A 2othA-3on6A:
undetectable		 2othA-3on6A:
12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p2c PUTATIVE GLYCOSYL
HYDROLASE

(Bacteroides
ovatus) 		PF06824
(Glyco_hydro_125) 		4 LEU A 263
ALA A 287
ILE A 186
SER A 283
 None
 1.01A 2othA-3p2cA:
undetectable		 2othA-3p2cA:
12.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pe8 ENOYL-COA HYDRATASE

(Mycolicibacterium
smegmatis) 		PF00378
(ECH_1) 		4 LEU A 169
ALA A 115
ILE A  95
LYS A 143
 None
 1.03A 2othA-3pe8A:
undetectable		 2othA-3pe8A:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qyr ECHA16_2

(Mycobacterium
avium) 		PF00378
(ECH_1) 		4 LEU A 168
ALA A 114
ILE A  94
LYS A 142
 None
 0.99A 2othA-3qyrA:
undetectable		 2othA-3qyrA:
17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r44 FATTY ACYL COA
SYNTHETASE FADD13
(FATTY-ACYL-COA
SYNTHETASE)

(Mycobacterium
tuberculosis) 		PF00501
(AMP-binding)
PF13193
(AMP-binding_C) 		4 LEU A 493
ALA A 477
ILE A 475
LYS A 490
 None
 0.95A 2othA-3r44A:
undetectable		 2othA-3r44A:
13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rko NADH-QUINONE
OXIDOREDUCTASE
SUBUNIT A
NADH-QUINONE
OXIDOREDUCTASE
SUBUNIT J

(Escherichia
coli) 		PF00507
(Oxidored_q4)
no annotation 		4 LEU A  20
ALA J  53
ILE J  56
SER J  40
 None
 0.85A 2othA-3rkoA:
2.2		 2othA-3rkoA:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s5k FALCILYSIN

(Plasmodium
falciparum) 		PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
PF08367
(M16C_assoc) 		4 LEU A 422
ALA A 505
ILE A 781
SER A 501
 None
 0.95A 2othA-3s5kA:
undetectable		 2othA-3s5kA:
6.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sun DNA POLYMERASE

(Escherichia
virus RB69) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		4 ALA A 780
ILE A 779
SER A 778
LYS A 859
 None
 1.08A 2othA-3sunA:
2.0		 2othA-3sunA:
8.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsm INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE

(Brucella
abortus) 		PF00218
(IGPS) 		4 LEU A  95
ALA A  64
ILE A  71
LYS A 122
 None
 1.06A 2othA-3tsmA:
undetectable		 2othA-3tsmA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u0b OXIDOREDUCTASE,
SHORT CHAIN
DEHYDROGENASE/REDUCT
ASE FAMILY PROTEIN

(Mycolicibacterium
smegmatis) 		PF13561
(adh_short_C2) 		4 LEU A 366
ALA A 383
ILE A 364
SER A 342
 None
 1.01A 2othA-3u0bA:
undetectable		 2othA-3u0bA:
14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3up8 PUTATIVE
2,5-DIKETO-D-GLUCONI
C ACID REDUCTASE B

(Sinorhizobium
meliloti) 		PF00248
(Aldo_ket_red) 		4 LEU A 104
ALA A 145
ILE A 153
SER A 149
 None
 0.95A 2othA-3up8A:
undetectable		 2othA-3up8A:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vti HYDROGENASE
MATURATION FACTOR

(Caldanaerobacter
subterraneus) 		PF00586
(AIRS)
PF02769
(AIRS_C) 		4 LEU C 284
ALA C 196
ILE C 210
SER C 199
 None
 1.01A 2othA-3vtiC:
undetectable		 2othA-3vtiC:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3woy CLIP-ASSOCIATING
PROTEIN 2

(Homo sapiens) 		PF12348
(CLASP_N) 		4 LEU A  88
ALA A 122
ILE A  80
SER A 118
 None
 1.11A 2othA-3woyA:
undetectable		 2othA-3woyA:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4apm APICAL MEMBRANE
ANTIGEN 1

(Babesia
divergens) 		PF02430
(AMA-1) 		4 ALA A 312
ILE A 313
SER A 429
LYS A 491
 None
None
None
ACT  A1513 (-2.7A)
 1.11A 2othA-4apmA:
undetectable		 2othA-4apmA:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bwr PROTEIN
CORRESPONDING TO
LOCUS C5321 FROM
CFT073 E.COLI STRAIN

(Escherichia
coli) 		PF08238
(Sel1) 		4 LEU A 197
ALA A 234
ILE A 233
SER A 232
 None
None
None
EDO  A1493 ( 3.7A)
 0.99A 2othA-4bwrA:
undetectable		 2othA-4bwrA:
14.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h0s BASIC PHOSPHOLIPASE
A2 HOMOLOG CTS-R6

(Trimeresurus
stejnegeri) 		PF00068
(Phospholip_A2_1) 		4 LEU A   2
ILE A  19
SER A  23
LYS A  69
 None
 1.13A 2othA-4h0sA:
20.4		 2othA-4h0sA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jjt ENOYL-COA HYDRATASE

(Mycobacterium
tuberculosis) 		PF00378
(ECH_1) 		4 LEU A 168
ALA A 114
ILE A  94
LYS A 142
 None
 1.00A 2othA-4jjtA:
undetectable		 2othA-4jjtA:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lqk PROTEIN A46

(Vaccinia virus) 		no annotation 4 LEU C  95
ALA C 185
ILE C 188
SER C 165
 None
 1.08A 2othA-4lqkC:
undetectable		 2othA-4lqkC:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lub PUTATIVE PREPHENATE
DEHYDRATASE

(Streptococcus
mutans) 		PF00800
(PDT) 		4 LEU A  71
ALA A 200
ILE A 243
SER A 198
 None
 0.87A 2othA-4lubA:
undetectable		 2othA-4lubA:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nar PUTATIVE URONATE
ISOMERASE

(Thermotoga
maritima) 		PF09861
(DUF2088) 		4 LEU A  33
ALA A 216
ILE A 214
SER A 218
 None
 1.06A 2othA-4narA:
undetectable		 2othA-4narA:
13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o6m AF2299, A
CDP-ALCOHOL
PHOSPHOTRANSFERASE

(Archaeoglobus
fulgidus) 		PF01066
(CDP-OH_P_transf) 		4 LEU A  72
ALA A 115
ILE A  59
LYS A  70
 None
 0.99A 2othA-4o6mA:
undetectable		 2othA-4o6mA:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p52 HOMOSERINE KINASE

(Cytophaga
hutchinsonii) 		PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C) 		4 LEU A 250
ALA A 268
ILE A 279
SER A 270
 None
 1.08A 2othA-4p52A:
undetectable		 2othA-4p52A:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q0c VIRULENCE SENSOR
PROTEIN BVGS

(Bordetella
pertussis) 		PF00497
(SBP_bac_3) 		4 LEU A 518
ALA A 335
ILE A 332
SER A 333
 None
 1.14A 2othA-4q0cA:
undetectable		 2othA-4q0cA:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q88 UNCHARACTERIZED
PROTEIN

(Bacteroides
vulgatus) 		PF07470
(Glyco_hydro_88) 		4 LEU A 305
ALA A 262
ILE A 261
SER A 260
 None
 1.11A 2othA-4q88A:
undetectable		 2othA-4q88A:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rt6 HEME/HEMOPEXIN-BINDI
NG PROTEIN

(Haemophilus
influenzae) 		PF05860
(Haemagg_act) 		4 LEU A 358
ALA A 363
ILE A 383
SER A 391
 None
 1.14A 2othA-4rt6A:
undetectable		 2othA-4rt6A:
8.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tkr THIAMINE TRANSPORTER
THIA

(Listeria
monocytogenes) 		PF09515
(Thia_YuaJ) 		4 LEU A 104
ALA A 116
ILE A 113
SER A 173
 None
None
BGL  A 305 ( 4.8A)
BGL  A 305 ( 3.9A)
 0.96A 2othA-4tkrA:
undetectable		 2othA-4tkrA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xpd N-TERMINAL
ACETYLTRANSFERASE A
COMPLEX SUBUNIT NAT1

(Saccharomyces
cerevisiae) 		PF12569
(NARP1) 		4 LEU A 553
ALA A 671
ILE A 488
LYS A 549
 None
 0.79A 2othA-4xpdA:
undetectable		 2othA-4xpdA:
8.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y7i MYOTUBULARIN-RELATED
PROTEIN 8

(Homo sapiens) 		PF06602
(Myotub-related) 		4 LEU A 335
ALA A 201
ILE A 202
SER A 192
 None
 1.04A 2othA-4y7iA:
undetectable		 2othA-4y7iA:
15.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ypl LON PROTEASE

(Meiothermus
taiwanensis) 		PF00004
(AAA)
PF05362
(Lon_C) 		4 LEU A 420
ALA A 369
ILE A 368
SER A 367
 None
 0.87A 2othA-4yplA:
undetectable		 2othA-4yplA:
11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yw5 NEURAMINIDASE C

(Streptococcus
pneumoniae) 		PF02012
(BNR)
PF02973
(Sialidase)
PF13088
(BNR_2) 		4 LEU A 219
ALA A 194
SER A 196
LYS A 167
 None
 1.15A 2othA-4yw5A:
undetectable		 2othA-4yw5A:
10.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zi5 P91

(metagenome) 		PF01738
(DLH) 		4 LEU A 231
ALA A 113
ILE A 137
SER A 157
 None
 1.06A 2othA-4zi5A:
undetectable		 2othA-4zi5A:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a5l D-FRUCTOSE
1,6-BISPHOSPHATASE
CLASS
2/SEDOHEPTULOSE
1,7-BISPHOSPHATASE

(Thermosynechococcus
elongatus) 		PF03320
(FBPase_glpX) 		4 LEU A 217
ALA A 206
SER A 202
LYS A 134
 None
None
None
VTB  A1339 (-3.6A)
 1.11A 2othA-5a5lA:
1.3		 2othA-5a5lA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5auo ATPASE INVOLVED IN
CHROMOSOME
PARTITIONING,
PARA/MIND FAMILY,
MRP HOMOLOG

(Thermococcus
kodakarensis) 		PF10609
(ParA) 		4 LEU B  56
ALA B 113
ILE B 110
SER B 111
 None
 1.15A 2othA-5auoB:
undetectable		 2othA-5auoB:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bjx WLAL PROTEIN

(Campylobacter
jejuni) 		no annotation 4 LEU A 299
ALA A 279
ILE A 312
SER A 285
 None
 1.08A 2othA-5bjxA:
undetectable		 2othA-5bjxA:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ed1 DOUBLE-STRANDED
RNA-SPECIFIC EDITASE
1

(Homo sapiens) 		PF02137
(A_deamin) 		4 LEU A 547
ALA A 324
ILE A 584
SER A 328
 None
 1.10A 2othA-5ed1A:
undetectable		 2othA-5ed1A:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iao BIFUNCTIONAL PROTEIN
PYRR

(Mycobacterium
tuberculosis) 		PF00156
(Pribosyltran) 		4 LEU A 117
ALA A 134
ILE A  85
SER A 130
 None
 1.12A 2othA-5iaoA:
undetectable		 2othA-5iaoA:
17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iao BIFUNCTIONAL PROTEIN
PYRR

(Mycobacterium
tuberculosis) 		PF00156
(Pribosyltran) 		4 LEU A 146
ALA A 131
ILE A  55
SER A 127
 None
 1.09A 2othA-5iaoA:
undetectable		 2othA-5iaoA:
17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lnx ACYL-COA
DEHYDROGENASE

(Bacillus
subtilis) 		PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N) 		4 LEU A  69
ALA A 246
ILE A  71
SER A  75
 None
 1.12A 2othA-5lnxA:
undetectable		 2othA-5lnxA:
13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nil MACROLIDE EXPORT
ATP-BINDING/PERMEASE
PROTEIN MACB

(Escherichia
coli) 		PF00005
(ABC_tran)
PF02687
(FtsX)
PF12704
(MacB_PCD) 		4 LEU J 134
ALA J 156
ILE J 155
SER J 154
 None
 0.92A 2othA-5nilJ:
undetectable		 2othA-5nilJ:
10.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vfk UNCHARACTERIZED
PROTEIN

(Sulfolobus
solfataricus) 		no annotation 4 LEU A 111
ALA A  90
SER A  92
LYS A 110
 None
 1.05A 2othA-5vfkA:
undetectable		 2othA-5vfkA:
23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ws4 MACROLIDE EXPORT
ATP-BINDING/PERMEASE
PROTEIN MACB

(Acinetobacter
baumannii) 		no annotation 4 LEU A 136
ALA A 158
ILE A 157
SER A 156
 None
 0.98A 2othA-5ws4A:
0.9		 2othA-5ws4A:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x3h URACIL-DNA
GLYCOSYLASE

(Nitratifractor
salsuginis) 		no annotation 4 LEU A 148
ALA A 123
ILE A 120
LYS A 145
 None
 1.11A 2othA-5x3hA:
undetectable		 2othA-5x3hA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yay KN MOTIF AND ANKYRIN
REPEAT DOMAINS 1

(Mus musculus) 		no annotation 4 LEU A1279
ALA A1316
ILE A1315
SER A1314
 None
 1.09A 2othA-5yayA:
undetectable		 2othA-5yayA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bma INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE

(Campylobacter
jejuni) 		no annotation 4 LEU A  91
ALA A  60
ILE A  67
LYS A 118
 None
 1.04A 2othA-6bmaA:
undetectable		 2othA-6bmaA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eu6 AMMONIUM TRANSPORTER

(Candidatus
Kuenenia
stuttgartiensis) 		no annotation 4 LEU A 254
ALA A 272
ILE A 304
SER A 268
 None
 1.01A 2othA-6eu6A:
undetectable		 2othA-6eu6A:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ezm IMIDAZOLEGLYCEROL-PH
OSPHATE DEHYDRATASE

(Saccharomyces
cerevisiae) 		no annotation 4 LEU U 100
ALA U 170
ILE U  98
SER U 166
 None
 1.09A 2othA-6ezmU:
undetectable		 2othA-6ezmU:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f4f GLUTATHIONE
TRANSFERASE

(Trametes
versicolor) 		no annotation 4 LEU A  40
ALA A  12
ILE A  56
SER A  15
 GDN  A 301 (-3.8A)
None
GDN  A 301 (-4.3A)
GDN  A 301 ( 3.7A)
 1.01A 2othA-6f4fA:
undetectable		 2othA-6f4fA:
18.18